28 March 2023

3D printed individualized oral dosage forms.
3D printing has opened up new opportunities and possibilities in many areas, including the development and manufacturing of pharmaceutical dosage forms.
read more
28 March 2023
3D printing has opened up new opportunities and possibilities in many areas, including the development and manufacturing of pharmaceutical dosage forms.
read more
16 February 2023
When it comes to OOS incidents, full traceability is essential. Visual inspection helps to precisely locate the source of the error and robust video monitoring can continue even when the automated process is unobserved on site.
read more
02 February 2023
With employment rates up and a historically high percentage of vacant jobs, automating your dissolution and sample preparation processes increases efficiency, improves traceability, and allows your lab personnel to focus on mission-critical activities.
read more
01 January 2023
SOTAX was established in 1973 and over the past 50 years, we have grown from a small regional business to a world-class global organization. Reason enough to celebrate!
read more
20 December 2022
As the year comes to an end, we would like to take this moment to review the past twelve months briefly and give a brief preview of what awaits us in the New Year.
read more
08 December 2022
Semi-solids, such as suspensions, creams, lotions, pastes, and gels, can pose problems to analytical method developers and analysts. Automating the required preparation steps with an APW workstation overcomes typical problems of manual preparation.
read more
22 November 2022
Did you know that you can collect data from Non-SOTAX instruments with q-doc® software? Standard drivers for balances, loss on drying (LOD), refraction, and other type of tests are readily available.
read more
03 November 2022
Recording the disintegration time of dosage forms such as hard-gelatine capsules can be challenging. Remaining residue (e.g. the empty capsule shell) makes it difficult to reliably determine the end-point for disintegration.
read more
29 September 2022
Are you struggling with deformulation, API characterization and prototypes comparison when developing a generic drug? Outsourcing these time-consuming initial steps to SOTAX Pharma Services can help you overcome bottlenecks and shortens time to market.
read more
28 September 2022
The SOTAX Group is pleased to confirm that Ortiv-Q3, a SOTAX joint-venture has received FDCA certification of compliance with Good Manufacturing Practice (GMP) for the testing of drugs and raw materials.
read more